Menopausal hormone therapy and risk of esophageal and gastric cancer in a multi-national study

Key Points

• To assess the association between menopausal hormone therapy and the risk of esophago-gastric cancer.
• Conducted a multi-national analysis
• Tracked cancer incidence among hormone therapy users and non-users
• MHT-users display significantly lower odds of esophago-gastric cancer development
• Findings suggest a protective effect of menopausal hormone therapy against these cancers